Results 211 to 220 of about 2,670,442 (349)

Causal Relationships Between Gastroesophageal Reflux Disease and Myocardial Infarction: Insights From Univariable and Multivariable Mendelian Randomization Analyses

Annals of Human Genetics, Volume 90, Issue 1, Page 52-62, January 2026.
ABSTRACT Background Observational studies have indicated that gastroesophageal reflux disease (GERD) is connected to myocardial infarction (MI). Nonetheless, the question of causality in these relationships remains unresolved, given the potential influence of confounding variables.
Xiaoya Zheng, Teng Hu, Tianxiang Fang, Pengpeng Su, Yingsong Wang, Ning Huangfu   +5 more
wiley   +1 more source

Chest pain management in acute coronary syndrome and chronic stable angina with diluted xylocaine injections. [PDF]

Bioinformation
Jain S, Jain R, Jain AD.
europepmc   +1 more source

Exercise-based cardiac rehabilitation for adults with stable angina.

Cochrane Database of Systematic Reviews, 2017
L. Long, Lindsey Anderson, A. Dewhirst, Jingzhou He, Charlene Bridges, M. Gandhi, R. Taylor   +6 more
semanticscholar   +1 more source

Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: A position statement of the European Expert Panel for Testosterone Research

Andrology, Volume 14, Issue 1, Page 294-302, January 2026.
Abstract Introduction Testosterone therapy has become a cornerstone treatment for men with hypogonadism, offering significant benefits such as improved sexual function, mood, muscle mass, and bone density. However, concerns about its cardiovascular safety have historically tempered its use.
Michael Zitzmann, Giulia Rastrelli, Robert D Murray, David Edwards, Yacov Reisman, Preethi Mohan Rao, Alexander Sahi, Thomas Hugh Jones, Alberto Ferlin, Eleni Armeni, Emiliano Corpas, Jann‐Frederik Cremers, Janine David, Stefan Arver, Leen Antonio, Giovanni Corona   +15 more
wiley   +1 more source

Impact of Medications for Stable Angina Pectoris on Osteoporosis: A Review of Current Evidence. [PDF]

J Multidiscip Healthc
Wang RA, Xu CX.
europepmc   +1 more source

Acute Reduction in Blood Flow in the Right Coronary Artery After PCI Facilitates Pacemaker‐Induced Ventricular Fibrillation

Annals of Noninvasive Electrocardiology, Volume 31, Issue 1, January 2026.
We present a case involving pacemaker sensing dysfunction caused by acute reduction in blood flow in the right coronary artery. The pacing spikes occurred progressively earlier on the T waves, eventually resulting in R‐on‐T pacing that triggered VF. ABSTRACT Asynchronous pacing itself does not directly lead to the development of malignant ventricular ...
Bo Wu, Yaqin Chen, Jianjun Tang, Jia He
wiley   +1 more source

Plaque vulnerability and thrombus formation according to area stenosis in chronic stable angina. [PDF]

Sci Rep
Shin ES, Oh JH, Nam CW, Koo BK.
europepmc   +1 more source

Frailty as a Key Determinant of Cardiovascular Risk and Mortality in Preserved Ratio Impaired Spirometry: A Nationally Representative Study

The Clinical Respiratory Journal, Volume 20, Issue 1, January 2026.
In adults with preserved ratio impaired spirometry (PRISm), frailty was common and strongly associated with increased cardiovascular events and all‐cause mortality. Frailty significantly improved risk stratification beyond traditional clinical factors. A frailty‐based nomogram demonstrated good discrimination and calibration, highlighting frailty as a ...
Yue Ren, Yixing Wu, Weiping Hu, Li Liu, Hui Cai, Jing Zhang   +5 more
wiley   +1 more source

Quality Evaluation of Literature Reports on Clinical Randomized Controlled Trials of Acupuncture Treatment for Stable Angina Pectoris. [PDF]

J Pain Res
Cai B, Su Z, Wang H, Li M, Gai X, Wei Y, Li M.   +6 more
europepmc   +1 more source

Intensive versus standard dose statin therapy: the costs and benefits for patients with acute coronary syndrome [PDF]

Introduction: Recent NICE guidance in England and Wales states that statin therapy for secondary CVD should "usually be initiated with a drug with a low acquisition cost (taking into account required daily dose and product price per dose)".
Ara, R., Hall, A.S., Pandor, A., Ward, S.   +3 more
core